Clinical Trial Update: Ridaforolimus in Treatment of Sarcoma-SUCCEED (Sarcoma Multi-Center Clinical Evaluation of the Efficacy of Ridaforolimus)(8669-011 AM6) [Phase 3]

View source ↗

Summary

The document reports the completion of the Phase 3 SUCCEED trial evaluating ridaforolimus in metastatic soft-tissue sarcoma and metastatic bone sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Sarcoma
• Soft-tissue Sarcoma

Drugs mentioned

• Ridaforolimus (ridaforolimus)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Metastatic Soft-Tissue Sarcomas, Metastatic Bone Sarcomas | Phase 3 | Status: COMPLETED